Filing Details
- Accession Number:
- 0001127602-17-027117
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-07 09:18:54
- Reporting Period:
- 2017-08-02
- Accepted Time:
- 2017-09-07 09:18:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
920148 | Laboratory Corp Of America Holdings | LH | Services-Medical Laboratories (8071) | 133757370 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1275654 | P David King | 531 South Spring Street Burlington NC 27215 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-08-02 | 1,650 | $0.00 | 214,066 | No | 5 | G | Direct | |
Common Stock | Acquisiton | 2017-09-05 | 132,713 | $90.74 | 346,779 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-09-05 | 132,713 | $157.06 | 214,066 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | G | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Options | Disposition | 2017-09-05 | 132,713 | $0.00 | 132,713 | $90.74 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
44,687 | 2012-02-09 | 2021-02-09 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 9,042 | Indirect | By grantor retained annuity trust |
Common Stock | 31,601 | Indirect | By grantor retained annuity trust |
Common Stock | 1,014 | Indirect | By grantor retained annuity trust |
Footnotes
- Amount includes 156.9666 shares acquired on June 30, 2017 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan and annuity payments from each of the reporting person's grantor retained annuity trusts to the reporting person in the amounts and on the dates indicated in notes 4 and 5 below.
- Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
- The price of $157.0560 per share represents a weighted average of sales prices ranging from $157.00 to $157.48 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- Amount reflects an annuity payment of 7,900 shares made by the trust to the reporting person on July 11, 2017.
- Amount reflects an annuity payment of 9,300 shares made by the trust to the reporting person on July 17, 2017.
- Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.
- The option vested in three equal annual installments beginning on 02/09/2011 and is now fully exercisable.